Vault-13

HighVista Strategies LLC

BOSTON, MA · CIK 1335325 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2012 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Associate Accounting And Performance ReportingBoston, MA 2 $100,000
Quantitative AnalystBoston, MA 1 $130,000
Investment AnalystBoston, MA 1 $100,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: HighVista Strategies LLC..

$165.6m reported value +5.3% vs Q1 2022
110positions
40.9%in top 10
39 new 43 added 18 reduced 15 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 DELL TECHNOLOGIES INC CL C DELL DELL 355,444 $16.4m9.92% 9.92% UnchangedShares held: Q3 2021 355.4k, Q4 2021 355.4k, Q1 2022 355.4k, Q2 2022 355.4k
2 MASTERCARD INCORPORATED CL A MA MA 37,024 $11.7m7.05% 7.05% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 24.2k, Q2 2022 37.0k +12.8k +12,820 53.0%
3 VISA INC COM CL A V V 43,257 $8.5m5.14% 5.14% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 41.1k, Q2 2022 43.3k +2.1k +2,122 5.2%
4 FISERV INC COM FISV FISV 86,334 $7.7m4.64% 4.64% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 83.3k, Q2 2022 86.3k +3.0k +3,048 3.7%
5 MSD ACQUISITION CORP UNIT 03/25/2026 MSDAU MSDAU 500,000 $4.9m2.98% 2.98% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
6 KURA ONCOLOGY INC COM KURA KURA 217,895 $4.0m2.41% 2.41% AddedShares held: Q3 2021 70.9k, Q4 2021 82.1k, Q1 2022 147.8k, Q2 2022 217.9k +70.1k +70,062 47.4%
7 CHANGE HEALTHCARE INC COM CHNG CHNG 162,100 $3.7m2.26% 2.26% UnchangedShares held: Q3 2021 162.1k, Q4 2021 162.1k, Q1 2022 162.1k, Q2 2022 162.1k
8 PAYPAL HLDGS INC COM PYPL PYPL 53,302 $3.7m2.25% 2.25% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.7k, Q2 2022 53.3k +2.6k +2,584 5.1%
9 COHERENT INC COM COHR COHR 13,600 $3.6m2.19% 2.19% UnchangedShares held: Q3 2021 0, Q4 2021 13.6k, Q1 2022 13.6k, Q2 2022 13.6k
10 ISHARES TR RUS 1000 VAL ETF IWD IWD 23,825 $3.5m2.09% 2.09% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 23.8k
11 COUPANG INC CL A CPNG CPNG 256,264 $3.3m1.97% 1.97% UnchangedShares held: Q3 2021 256.3k, Q4 2021 256.3k, Q1 2022 256.3k, Q2 2022 256.3k
12 ACTIVISION BLIZZARD INC COM ATVI ATVI 40,000 $3.1m1.88% 1.88% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 40.0k, Q2 2022 40.0k
13 CITRIX SYS INC COM CTXS CTXS 31,400 $3.1m1.84% 1.84% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 31.4k, Q2 2022 31.4k
14 ACLARIS THERAPEUTICS INC COM ACRS ACRS 217,528 $3.0m1.83% 1.83% AddedShares held: Q3 2021 93.0k, Q4 2021 112.2k, Q1 2022 158.2k, Q2 2022 217.5k +59.3k +59,285 37.5%
15 TEGNA INC COM TGNA TGNA 144,000 $3.0m1.82% 1.82% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 144.0k
16 TURNING POINT THERAPEUTICS I COM COM 39,384 $3.0m1.79% 1.79% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 21.0k, Q2 2022 39.4k +18.3k +18,347 87.2%
17 FIRST HORIZON CORPORATION COM FHN FHN 135,400 $3.0m1.79% 1.79% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 135.4k, Q2 2022 135.4k
18 FATE THERAPEUTICS INC COM FATE FATE 118,778 $2.9m1.78% 1.78% AddedShares held: Q3 2021 17.1k, Q4 2021 23.1k, Q1 2022 64.7k, Q2 2022 118.8k +54.1k +54,113 83.7%
19 CYTOKINETICS INC COM NEW CYTK CYTK 67,502 $2.7m1.60% 1.60% AddedShares held: Q3 2021 0, Q4 2021 35.2k, Q1 2022 65.8k, Q2 2022 67.5k +1.7k +1,733 2.6%
20 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 151,207 $2.5m1.53% 1.53% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 18.3k, Q2 2022 151.2k +132.9k +132,909 726.4%
21 TRAVERE THERAPEUTICS INC COM TVTX TVTX 104,150 $2.5m1.52% 1.52% AddedShares held: Q3 2021 56.7k, Q4 2021 54.1k, Q1 2022 32.5k, Q2 2022 104.2k +71.6k +71,649 220.4%
22 TWITTER INC COM TWTR TWTR 64,000 $2.4m1.44% 1.44% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 64.0k
23 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 74,261 $2.4m1.43% 1.43% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 51.1k, Q2 2022 74.3k +23.2k +23,176 45.4%
24 REPARE THERAPEUTICS INC COM RPTX RPTX 152,600 $2.1m1.29% 1.29% AddedShares held: Q3 2021 36.1k, Q4 2021 43.5k, Q1 2022 143.4k, Q2 2022 152.6k +9.2k +9,225 6.4%
25 APELLIS PHARMACEUTICALS INC COM APLS APLS 46,141 $2.1m1.26% 1.26% AddedShares held: Q3 2021 19.8k, Q4 2021 0, Q1 2022 36.9k, Q2 2022 46.1k +9.2k +9,248 25.1%
26 CATALYST PARTNRS ACQUISITN C UNIT 99/99/9999 UNIT 99/99/9999 200,000 $2.0m1.18% 1.18% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
27 NOVOCURE LTD ORD SHS NVCR NVCR 28,007 $1.9m1.17% 1.17% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 17.4k, Q2 2022 28.0k +10.6k +10,559 60.5%
28 RELAY THERAPEUTICS INC COM RLAY RLAY 113,313 $1.9m1.15% 1.15% AddedShares held: Q3 2021 37.7k, Q4 2021 46.0k, Q1 2022 68.6k, Q2 2022 113.3k +44.7k +44,705 65.2%
29 ARCUS BIOSCIENCES INC COM RCUS RCUS 71,650 $1.8m1.10% 1.10% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 71.7k +21.6k +21,600 43.2%
30 IDEAYA BIOSCIENCES INC COM IDYA IDYA 130,380 $1.8m1.09% 1.09% AddedShares held: Q3 2021 0, Q4 2021 40.6k, Q1 2022 49.5k, Q2 2022 130.4k +80.9k +80,853 163.2%
31 BIOMEA FUSION INC COM BMEA BMEA 144,727 $1.7m1.05% 1.05% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 112.9k, Q2 2022 144.7k +31.8k +31,809 28.2%
32 DYNE THERAPEUTICS INC COM DYN DYN 241,867 $1.7m1.00% 1.00% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 168.7k, Q2 2022 241.9k +73.2k +73,176 43.4%
33 GENERATION BIO CO COM COM 248,994 $1.6m0.99% 0.99% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 131.3k, Q2 2022 249.0k +117.7k +117,699 89.6%
34 CYMABAY THERAPEUTICS INC COM CBAY CBAY 395,332 $1.2m0.70% 0.70% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 207.3k, Q2 2022 395.3k +188.0k +188,025 90.7%
35 INVESCO DB COMMDY INDX TRCK UNIT DBC DBC 42,396 $1.1m0.68% 0.68% UnchangedShares held: Q3 2021 42.4k, Q4 2021 42.4k, Q1 2022 42.4k, Q2 2022 42.4k
36 KARYOPHARM THERAPEUTICS INC COM COM 250,377 $1.1m0.68% 0.68% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 250.4k
37 MICROSOFT CORP COM MSFT MSFT 3,988 $1.0m0.62% 0.62% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 4.0k
38 AMICUS THERAPEUTICS INC COM FOLD FOLD 90,234 $969.0k0.59% 0.59% ReducedShares held: Q3 2021 113.4k, Q4 2021 113.4k, Q1 2022 108.3k, Q2 2022 90.2k -18.0k -18,023 -16.6%
39 BRIDGEBIO PHARMA INC COM BBIO BBIO 105,942 $962.0k0.58% 0.58% AddedShares held: Q3 2021 24.7k, Q4 2021 33.9k, Q1 2022 85.3k, Q2 2022 105.9k +20.6k +20,642 24.2%
40 MERUS N V COM MRUS MRUS 40,481 $916.0k0.55% 0.55% AddedShares held: Q3 2021 0, Q4 2021 53.8k, Q1 2022 30.4k, Q2 2022 40.5k +10.1k +10,093 33.2%
41 CHINOOK THERAPEUTICS INC COM ADRO ADRO 50,834 $889.0k0.54% 0.54% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 67.8k, Q2 2022 50.8k -16.9k -16,943 -25.0%
42 IMMUNOGEN INC COM IMGN IMGN 191,726 $863.0k0.52% 0.52% AddedShares held: Q3 2021 24.1k, Q4 2021 0, Q1 2022 77.7k, Q2 2022 191.7k +114.0k +114,032 146.8%
43 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 103,462 $824.0k0.50% 0.50% AddedShares held: Q3 2021 39.1k, Q4 2021 0, Q1 2022 59.7k, Q2 2022 103.5k +43.7k +43,729 73.2%
44 ARGENX SE SPONSORED ADR ARGX ARGX 2,153 $816.0k0.49% 0.49% ReducedShares held: Q3 2021 3.7k, Q4 2021 5.6k, Q1 2022 3.1k, Q2 2022 2.2k -908 -908 -29.7%
45 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 3,452 $813.0k0.49% 0.49% AddedShares held: Q3 2021 5.9k, Q4 2021 6.3k, Q1 2022 2.7k, Q2 2022 3.5k +795 +795 29.9%
46 BEAM THERAPEUTICS INC COM BEAM BEAM 20,980 $812.0k0.49% 0.49% AddedShares held: Q3 2021 11.5k, Q4 2021 13.5k, Q1 2022 11.1k, Q2 2022 21.0k +9.9k +9,878 89.0%
47 GOSSAMER BIO INC COM GOSS GOSS 96,795 $810.0k0.49% 0.49% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 70.0k, Q2 2022 96.8k +26.8k +26,753 38.2%
48 KRYSTAL BIOTECH INC COM KRYS KRYS 12,225 $803.0k0.48% 0.48% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 12.2k
49 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 28,450 $752.0k0.45% 0.45% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 28.4k
50 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 500,680 $746.0k0.45% 0.45% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 476.7k, Q2 2022 500.7k +23.9k +23,936 5.0%
51 MIRATI THERAPEUTICS INC COM MRTX MRTX 11,096 $745.0k0.45% 0.45% AddedShares held: Q3 2021 8.5k, Q4 2021 9.2k, Q1 2022 9.8k, Q2 2022 11.1k +1.3k +1,343 13.8%
52 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 34,462 $734.0k0.44% 0.44% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 34.5k
53 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 4,988 $728.0k0.44% 0.44% ReducedShares held: Q3 2021 6.2k, Q4 2021 7.1k, Q1 2022 5.6k, Q2 2022 5.0k -567 -567 -10.2%
54 SAREPTA THERAPEUTICS INC COM SRPT SRPT 9,581 $718.0k0.43% 0.43% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 11.3k, Q2 2022 9.6k -1.7k -1,729 -15.3%
55 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 8,596 $712.0k0.43% 0.43% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 5.6k, Q2 2022 8.6k +3.0k +3,003 53.7%
56 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 7,442 $692.0k0.42% 0.42% ReducedShares held: Q3 2021 9.8k, Q4 2021 8.5k, Q1 2022 7.8k, Q2 2022 7.4k -379 -379 -4.8%
57 XENON PHARMACEUTICALS INC COM XENE XENE 22,435 $682.0k0.41% 0.41% ReducedShares held: Q3 2021 75.0k, Q4 2021 62.9k, Q1 2022 28.0k, Q2 2022 22.4k -5.6k -5,557 -19.9%
58 ANAPTYSBIO INC COM ANAB ANAB 33,103 $672.0k0.41% 0.41% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 14.0k, Q2 2022 33.1k +19.1k +19,105 136.5%
59 TRICIDA INC COM TCDA TCDA 68,548 $664.0k0.40% 0.40% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 107.2k, Q2 2022 68.5k -38.7k -38,654 -36.1%
60 ARVINAS INC COM ARVN ARVN 15,686 $660.0k0.40% 0.40% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 15.7k
61 GALAPAGOS NV SPON ADR LKFT LKFT 11,801 $658.0k0.40% 0.40% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 13.2k, Q2 2022 11.8k -1.4k -1,408 -10.7%
62 ALPHABET INC CAP STK CL C GOOG GOOG 296 $647.0k0.39% 0.39% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 296
63 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 63,936 $638.0k0.39% 0.39% AddedShares held: Q3 2021 0, Q4 2021 27.0k, Q1 2022 52.8k, Q2 2022 63.9k +11.1k +11,096 21.0%
64 MORPHIC HLDG INC COM MORF MORF 29,230 $634.0k0.38% 0.38% AddedShares held: Q3 2021 20.3k, Q4 2021 23.8k, Q1 2022 10.9k, Q2 2022 29.2k +18.3k +18,313 167.8%
65 NATERA INC COM NTRA NTRA 17,812 $631.0k0.38% 0.38% AddedShares held: Q3 2021 11.0k, Q4 2021 11.0k, Q1 2022 13.4k, Q2 2022 17.8k +4.4k +4,364 32.5%
66 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 32,948 $614.0k0.37% 0.37% ReducedShares held: Q3 2021 0, Q4 2021 53.0k, Q1 2022 44.2k, Q2 2022 32.9k -11.3k -11,278 -25.5%
67 BLUEPRINT MEDICINES CORP COM BPMC BPMC 12,108 $612.0k0.37% 0.37% NewShares held: Q3 2021 12.7k, Q4 2021 13.8k, Q1 2022 0, Q2 2022 12.1k
68 VAXCYTE INC COM PCVX PCVX 27,965 $609.0k0.37% 0.37% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 28.0k
69 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 22,412 $604.0k0.36% 0.36% ReducedShares held: Q3 2021 28.5k, Q4 2021 29.9k, Q1 2022 25.7k, Q2 2022 22.4k -3.3k -3,326 -12.9%
70 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 7,419 $592.0k0.36% 0.36% ReducedShares held: Q3 2021 11.3k, Q4 2021 11.3k, Q1 2022 8.3k, Q2 2022 7.4k -837 -837 -10.1%
71 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 39,900 $562.0k0.34% 0.34% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 34.1k, Q2 2022 39.9k +5.8k +5,784 16.9%
72 RELMADA THERAPEUTICS INC COM RLMD RLMD 29,493 $560.0k0.34% 0.34% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 21.4k, Q2 2022 29.5k +8.1k +8,112 37.9%
73 IVERIC BIO INC COM OPHT OPHT 57,919 $557.0k0.34% 0.34% AddedShares held: Q3 2021 63.1k, Q4 2021 101.1k, Q1 2022 53.6k, Q2 2022 57.9k +4.3k +4,336 8.1%
74 AMAZON COM INC COM AMZN AMZN 5,068 $538.0k0.32% 0.32% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 5.1k
75 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 45,039 $521.0k0.31% 0.31% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 49.1k, Q2 2022 45.0k -4.0k -4,026 -8.2%
76 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 44,962 $496.0k0.30% 0.30% ReducedShares held: Q3 2021 56.3k, Q4 2021 66.6k, Q1 2022 54.4k, Q2 2022 45.0k -9.4k -9,439 -17.4%
77 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 19,080 $470.0k0.28% 0.28% AddedShares held: Q3 2021 15.6k, Q4 2021 17.9k, Q1 2022 7.8k, Q2 2022 19.1k +11.3k +11,325 146.0%
78 KEROS THERAPEUTICS INC COM KROS KROS 16,623 $459.0k0.28% 0.28% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 16.0k, Q2 2022 16.6k +583 +583 3.6%
79 PTC INC COM PTC PTC 4,310 $458.0k0.28% 0.28% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 4.3k
80 REGENXBIO INC COM RGNX RGNX 16,352 $404.0k0.24% 0.24% NewShares held: Q3 2021 0, Q4 2021 29.8k, Q1 2022 0, Q2 2022 16.4k
81 REVOLUTION MEDICINES INC COM RVMD RVMD 20,685 $403.0k0.24% 0.24% NewShares held: Q3 2021 23.6k, Q4 2021 0, Q1 2022 0, Q2 2022 20.7k
82 ITEOS THERAPEUTICS INC COM ITOS ITOS 18,913 $390.0k0.24% 0.24% ReducedShares held: Q3 2021 0, Q4 2021 34.5k, Q1 2022 22.8k, Q2 2022 18.9k -3.9k -3,899 -17.1%
83 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 3,767 $367.0k0.22% 0.22% NewShares held: Q3 2021 13.2k, Q4 2021 0, Q1 2022 0, Q2 2022 3.8k
84 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 46,459 $367.0k0.22% 0.22% ReducedShares held: Q3 2021 28.3k, Q4 2021 31.0k, Q1 2022 92.0k, Q2 2022 46.5k -45.6k -45,586 -49.5%
85 AVIDITY BIOSCIENCES INC COM RNA RNA 24,864 $361.0k0.22% 0.22% ReducedShares held: Q3 2021 56.9k, Q4 2021 44.3k, Q1 2022 53.2k, Q2 2022 24.9k -28.3k -28,300 -53.2%
86 SERVICENOW INC COM NOW NOW 732 $348.0k0.21% 0.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 732
87 T-MOBILE US INC COM TMUS TMUS 2,588 $348.0k0.21% 0.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.6k
88 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 4,800 $344.0k0.21% 0.21% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 4.5k, Q2 2022 4.8k +275 +275 6.1%
89 BELLUS HEALTH INC NEW COM NEW BLU BLU 36,364 $336.0k0.20% 0.20% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 65.2k, Q2 2022 36.4k -28.8k -28,810 -44.2%
90 PMV PHARMACEUTICALS INC COM PMVP PMVP 23,324 $332.0k0.20% 0.20% NewShares held: Q3 2021 39.8k, Q4 2021 39.8k, Q1 2022 0, Q2 2022 23.3k
91 BILIBILI INC SPONS ADS REP Z BILI BILI 12,770 $327.0k0.20% 0.20% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 12.8k
92 JD.COM INC SPON ADR CL A JD JD 5,098 $327.0k0.20% 0.20% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 5.1k
93 PROMETHEUS BIOSCIENCES INC COM COM 10,782 $304.0k0.18% 0.18% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 10.8k
94 AUTODESK INC COM ADSK ADSK 1,766 $303.0k0.18% 0.18% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.8k
95 I MAB SPONSORED ADS NBP NBP 26,534 $300.0k0.18% 0.18% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 25.4k, Q2 2022 26.5k +1.1k +1,132 4.5%
96 BLUCORA INC COM BCOR BCOR 15,872 $293.0k0.18% 0.18% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 15.9k
97 WILLIS TOWERS WATSON PLC LTD SHS WTW WTW 1,474 $291.0k0.18% 0.18% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.5k
98 AUTOLIV INC COM ALV ALV 3,914 $281.0k0.17% 0.17% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 3.9k
99 SALESFORCE INC COM CRM CRM 1,676 $277.0k0.17% 0.17% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.7k
100 EXPEDIA GROUP INC COM NEW EXPE EXPE 2,592 $246.0k0.15% 0.15% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.6k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
PEOPLES UNITED FINANCIAL INC PBCT PBCT 196,100 $3.9m196.1k shares
FIDELITY NATL INFORMATION SV FIS FIS 38,303 $3.8m38.3k shares
CERNER CORP CERN CERN 37,300 $3.5m37.3k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 12,678 $1.5m12.7k shares
VERTEX PHARMACEUTICALS INC VRTX VRTX 3,752 $979.0k3.8k shares
DICE THERAPEUTICS INC 48,960 $937.0k49.0k shares
C4 THERAPEUTICS INC CCCC CCCC 34,760 $843.0k34.8k shares
ROCKET PHARMACEUTICALS INC RCKT RCKT 48,191 $764.0k48.2k shares
NGM BIOPHARMACEUTICALS INC NGM NGM 46,243 $705.0k46.2k shares
INVITAE CORP NVTA NVTA 75,472 $602.0k75.5k shares
PROTHENA CORP PLC PRTA PRTA 12,953 $474.0k13.0k shares
VISTAGEN THERAPEUTICS INC VTGN VTGN 315,880 $392.0k315.9k shares
BEIGENE LTD ONC ONC 2,002 $378.0k2.0k shares
GRITSTONE BIO INC GRTS GRTS 88,318 $364.0k88.3k shares
VERVE THERAPEUTICS INC 14,073 $321.0k14.1k shares